Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate for Osteoporosis in Men With Prostate Cancer
NCT00177619Phase 3Completed
- Sponsor
- University of Pittsburgh
- Start
- May 2002
- Primary completion
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoporosis comparing Alendronate with Placebo (2 arms). Primary endpoint: Change in spine bone mineral density at 2 years. Started May 2002; status: completed.
02
Drugs
alendronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00177619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00177619.